Companies · Other Health Care

Eagle Onsite, LlcNew on the radar

PEARLAND · Other Health Care

Diligence memoA one-page analyst read on Eagle Onsite, Llc — recommendation, valuation, rhythm, risks.
$3.5M
Total raised · real
1
Rounds
Latest step-up
Top 43%
Sector rank · raised
Seed
Latest stage · inferred · Tue May 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

Eagle Onsite, Llc looks over-valued against its niche peers and is active on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Over-valued
  • Modeled value is 2.51× the median modeled value of Seed Other Health Care companies in 2025–2027 (105 peers) — value vs value, same stage and era.
Active
  • Last raise 13 mo ago; this sector typically re-raises about every 14 months.
  • Raising on or ahead of the sector's normal rhythm.

Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.

Issuer-vehicle patternmedium confidence

Eagle Onsite, Llc behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.

Issuer structure
Company-like
No recurring-offering pattern strong enough to override normal financing interpretation.
Lifecycle
1.1 yr record
Peak capital year was 2025 with $3.5M across 1 filings.
Market position
ahead of 58% of Other Health Care peers
Capital scale is ahead of 58% of Other Health Care peers; modeled value is above 35% of peers by modeled value. Large capital with mid-pack modeled value can signal an issuer/program profile rather than operating-company growth.
Valuation reliability
Normal applicability
Stage/dilution valuation models are weakest when the issuer is broad-sector, recurring, or vehicle-like.
Operating evidence
Sparse
No clear CEO/founder/principal role is surfaced, so operating-company confidence is lower.
Data quality
Consistent
Canonical totals and visible filing detail are broadly aligned.
What triggered this
  • Legal name looks like an issuer vehicle rather than a product company.
  • No clearly named CEO/founder/principal role in the public records surfaced here.
  • No verified homepage on the profile yet.
  • Capital program peaked in 2025: $3.5M across 1 filings.
  • Largest single filing was $3.5M on 2025-05-20.
How to read the page
  • Read this less like a startup funding journey and more like a capital-raising program.
  • Stage-based valuation and peer labels have lower applicability for this pattern.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Eagle Onsite, Llc is one of 5376 Other Health Care companies tracked from PEARLAND. By capital raised it ranks mid-pack (ahead of 58% of sector peers), and in the long tail by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
1
Investors (latest)
2022
Year incorporated
2025-05-20
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$5.0M$10M$15M$20MSeed · 2025-05-20 Raised $3.5M (real) Modeled valuation $11M (est)$3.5M$11MSeed2025

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Seed$3.5M · 2025

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 50%.

Modeled valuation trajectory
$10.6M
Base estimate est.
$3.0M
Conservative case
$22.3M
Upside case
$17.5M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Seeda $1.0M–$4.0M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Not enough modeled valuation points to chart a trajectory.

Model inputs · modeled:benchmark-stage-stepup-v1
20%
Dilution assumption
Implied ownership sold in the financing.
38%
Survival probability
17% low · 58% high
1.54×/yr
Annual markup
2.01×/yr upside case
1.1 yr
Elapsed time used
1.1 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
Avg between rounds
Capital velocity
1.1 yr
On record since
2025
First round
New
First-time filer
How it compares to the market

Benchmarked against 5376 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 1.4× above median
This company$3.5M
Sector median$2.4M
Latest round — vs other Seed rounds in sector (real $, this stage) 2.1× above median
This company$3.5M
Sector median$1.7M
Modeled value — vs sector median (estimate, all stages) 0.5× of median
This company$10.6M
Sector median$22.1M

Raised more than 58% of sector peers (real $). Modeled value above 35% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Seed) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #8 of 105.

This companyCohort peer
$1.0M$10.0M$100.0M$1.0M$10.0M$100.0MCapital raised (log)Xymogen, Inc. · Seed Raised $62.4M · modeled $12.3M (est)Willow Life Sciences, Inc. · Seed Raised $4.0M · modeled $12.0M (est)ManyClicks, Inc. · Seed Raised $4.0M · modeled $11.6M (est)Sterile State, Inc. · Seed Raised $3.2M · modeled $11.4M (est)Limber Prosthetics, Inc. · Seed Raised $3.8M · modeled $11.1M (est)Othership Inc. · Seed Raised $3.7M · modeled $11.0M (est)Ps-Fertility, Inc. · Seed Raised $3.5M · modeled $11.0M (est)ForCast Orthopedics, Inc. · Seed Raised $3.8M · modeled $10.6M (est)1888 Equity LLC · Seed Raised $3.0M · modeled $10.5M (est)Arrellio, Inc. · Seed Raised $3.5M · modeled $10.0M (est)Kindbridge Corp · Seed Raised $5.4M · modeled $9.9M (est)Eagle Onsite, Llc (this company) Raised $3.5M · modeled $10.6M (est)Eagle Onsite, Llc
CompanyStageRaised · realValue · estvs peer med.
Xymogen, Inc.Seed$62.4M$12.3M2.89×
Willow Life Sciences, Inc.Seed$4.0M$12.0M2.84×
ManyClicks, Inc.Seed$4.0M$11.6M2.75×
Sterile State, Inc.Seed$3.2M$11.4M2.70×
Limber Prosthetics, Inc.Seed$3.8M$11.1M2.63×
Othership Inc.Seed$3.7M$11.0M2.61×
Ps-Fertility, Inc.Seed$3.5M$11.0M2.59×
Eagle Onsite, Llc this companySeed$3.5M$10.6M2.51×
ForCast Orthopedics, Inc.Seed$3.8M$10.6M2.50×
1888 Equity LLCSeed$3.0M$10.5M2.48×
Arrellio, Inc.Seed$3.5M$10.0M2.35×
Kindbridge CorpSeed$5.4M$9.9M2.33×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Seed$3.5M2025-05-20$17.5M$10.6M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Seed$3.5M2025-05-20
    • First recorded raise — entered as Seed.
    • 1 investor on this round.
Intelligence
Modeled next raise
$5.6M
Modeled next size est.range $3.6M$9.0M
Last step-up
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
John Darren Sanders2025-05
Registry & provenance

Eagle Onsite, Llc is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
2068815
SEC CIK
2022
Incorporated
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Arrellio, Inc.Other Health CareSeed$3.5M$10.0Msame sector · same stage
Ps-Fertility, Inc.Other Health CareSeed$3.5M$11.0Msame sector · same stage
Vymedic Inc.Other Health CareSeed$3.5M$10.3Msame sector · same stage
Nutek Orthopaedics IncOther Health CareSeed$3.5M$9.9Msame sector · same stage
VedaPointe, LLCOther Health CareSeed$3.4M$11.7Msame sector · same stage
Genoa-QoL Investment Holdings, LPOther Health CareSeed$3.6M$12.4Msame sector · same stage
VenX, LLCOther Health CareSeed$3.7M$10.3Msame sector · same stage
Aegis Impact & Innovation LLCOther Health CareSeed$3.4M$12.3Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
iDocsWeb, LLCOther Health CarePre-Seed$8.3M82%
OncoTracker, Inc.Other Health CareSeed$3.7M81%
OnLume Inc.Other Health CareSeries A$23.2M81%
ASD.me, LLCOther Health CarePre-Seed$4.4M81%
AcceleraME, IncOther Health CareSeed$4.2M81%
EmStop Inc.Other Health CareSeed$26.5M81%
Arche Inc.Other Health CareSeed$19.5M81%
Gravie, Inc.Other Health CareSeries C$1.3B81%
Frequently asked
How much funding has Eagle Onsite, Llc raised?
Eagle Onsite, Llc has raised approximately $3.5M in disclosed capital across 1 recorded financing round, aggregated from public filings.
What is Eagle Onsite, Llc's estimated valuation?
Provath's modeled valuation for Eagle Onsite, Llc is approximately $10.6M (modeled range $3.0M–$22.3M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Eagle Onsite, Llc at?
Eagle Onsite, Llc's latest modeled financing stage is Seed. Its most recent recorded round closed around Tue May 20.
What does Eagle Onsite, Llc do and where is it based?
Eagle Onsite, Llc operates in the Other Health Care sector, based in PEARLAND.
Explore related

See where Eagle Onsite, Llc sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Eagle Onsite, Llc, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.